Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,022Revenue $M25,526Net Margin (%)1.3Z-Score3.4
Enterprise Value $M12,460EPS $0.2Operating Margin %2.9F-Score7
P/E(ttm))25.4Cash Flow Per Share $0.1Pre-tax Margin (%)1.4Higher ROA y-yY
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0.6Cash flow > EarningsY
Price/Sales0.35-y EBITDA Growth Rate %17.9Current Ratio1.8Lower Leverage y-yY
Price/Cash Flow10.4y-y EBITDA Growth Rate %-1.7ROA % (ttm)4.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M982ROI % (ttm)-6.7Gross Margin Increase y-yN

Gurus Latest Trades with RAD

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RADNWQ Managers 2014-12-31 Buy 0.02%$4.51 - $7.56
($5.54)
$ 8.1748%New holding, 206300 sh.206,300
RADNWQ Managers 2014-12-31 Buy 0.02%$4.51 - $7.56
($5.54)
$ 8.1748%New holding, 206300 sh.206,300
RADJohn Burbank 2014-12-31 Sold Out $4.51 - $7.56
($5.56)
$ 8.1747%Sold Out0
RADJoel Greenblatt 2014-12-31 Reduce-0.45%$4.51 - $7.56
($5.56)
$ 8.1747%Reduce -73.14%3,434,880
RADJohn Hussman 2014-12-31 Sold Out -0.21%$4.51 - $7.56
($5.54)
$ 8.1748%Sold Out0
RADJoel Greenblatt 2014-09-30 Add0.47%$4.95 - $7.57
($6.45)
$ 8.1727%Add 304.2%12,788,466
RADRay Dalio 2014-09-30 Add0.07%$4.95 - $7.57
($6.45)
$ 8.1727%Add 808.47%2,124,000
RADJohn Burbank 2014-09-30 Add$4.95 - $7.57
($6.45)
$ 8.1727%Add 259.5%39,265
RADAndreas Halvorsen 2014-09-30 Sold Out -0.42%$4.95 - $7.57
($6.45)
$ 8.1727%Sold Out0
RADJohn Hussman 2014-09-30 Reduce-0.28%$4.95 - $7.57
($6.45)
$ 8.1727%Reduce -50%500,000
RADGeorge Soros 2014-09-30 Sold Out -0.12%$4.95 - $7.57
($6.45)
$ 8.1727%Sold Out0
RADAndreas Halvorsen 2014-06-30 Buy 0.42%$6.05 - $8.5
($7.38)
$ 8.1711%New holding, 13458963 sh.13,458,963
RADJoel Greenblatt 2014-06-30 Add0.27%$6.05 - $8.5
($7.38)
$ 8.1711%Add 1896.83%3,163,882
RADJohn Burbank 2014-06-30 Reduce$6.05 - $8.5
($7.38)
$ 8.1711%Reduce -58.8%10,922
RADDavid Einhorn 2014-06-30 Sold Out -0.52%$6.05 - $8.5
($7.38)
$ 8.1711%Sold Out0
RADRay Dalio 2014-06-30 Reduce-0.04%$6.05 - $8.5
($7.38)
$ 8.1711%Reduce -78.47%233,800
RADGeorge Soros 2014-03-31 Buy 0.13%$5.04 - $6.92
($6.06)
$ 8.1735%New holding, 2043700 sh.2,043,700
RADRay Dalio 2014-03-31 Add0.05%$5.04 - $6.92
($6.06)
$ 8.1735%Add 720.17%1,085,900
RADDavid Einhorn 2014-03-31 Reduce-0.46%$5.04 - $6.92
($6.06)
$ 8.1735%Reduce -54.53%5,511,246
RADJoel Greenblatt 2014-03-31 Reduce-0.1%$5.04 - $6.92
($6.06)
$ 8.1735%Reduce -83.8%158,445
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RAD is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
RAD NWQ Managers 2014-12-31206,3000.020.02New Buy
RAD Ray Dalio 2014-12-312,487,1940.250.15+17.1%
RAD Ken Fisher 2014-12-3110,85000+4.83%
RAD Joel Greenblatt 2014-12-313,434,8800.350.21-73.14%
RAD John Burbank 2014-12-31000Sold Out
RAD John Hussman 2014-12-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


RAD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Montini TonyEVP 2014-12-29Sell49,525$7.479.1view
Montini TonyEVP 2014-12-23Sell259,750$6.9217.77view
STANDLEY JOHN TChairmain/CEO 2014-12-22Sell1,700,000$6.8219.5view
Thompson Robert IvanEVP 2014-12-22Sell149,231$6.819.85view
Martindale KennethPresident/COO 2014-12-22Sell1,043,400$6.819.85view
VITRANO FRANKSEVP 2014-12-22Sell1,070,181$6.7920.03view
STRASSLER MARC AEVP 2014-12-22Sell575,975$6.7920.03view
Thompson Robert IvanEVP 2014-07-03Sell249,583$7.488.96view
ANDERSON JOSEPH B JRDirector 2014-06-24Sell26,667$7.0515.6view
Thompson Robert IvanEVP 2014-06-23Sell510,000$7.0615.44view

Press Releases about RAD :

    Quarterly/Annual Reports about RAD:

    News about RAD:

    Articles On GuruFocus.com
    Rite Aid Corporation is a Buy Feb 19 2015 
    This Drugstore Retailer Should Have A Better 2015 Feb 12 2015 
    My Picks Dec 18 2014 
    Do Not be a Victim – Rite Aid Stock Study Dec 17 2014 
    Are These Drugstore Retailers Good Investments? Dec 11 2014 
    Rite Aid Corporation Looks Promising Dec 05 2014 
    McKesson's Growth Is Set to Continue in the Long Run Nov 25 2014 
    Joel Greenblatt: the Value Investment Magician's Most Recent Buys Nov 20 2014 
    Why Rite Aid Continues To Look Attractive, Despite Some Fallouts Oct 17 2014 
    Guru Joel Greenblatt Gives Back Oct 08 2014 

    More From Other Websites
    Rite Aid Announces First-Ever Innovation Challenge Feb 24 2015
    Looking To Invest In the Third-Largest Pharmacy? Feb 23 2015
    Rite Aid Announces Winners of 11th Annual Favorite Pharmacy Team Member Contest Feb 20 2015
    Rite Aid to Acquire Leading Independent Pharmacy Benefit Manager EnvisionRx for $2 Billion Feb 19 2015
    Zacks.com featured expert Kevin Matras highlights: Rite Aid, Advanced Semiconductor Engineering,... Feb 19 2015
    Rite Aid Announces First-Ever Innovation Challenge Feb 19 2015
    Rite Aid Contributes $590,000 to the United Way of the Capital Region in 2014 Feb 18 2015
    Rite Aid Reports Same Store Sales for January Feb 18 2015
    Rite Aid Opens First RediClinics Inside Select Rite Aid Pharmacies Feb 18 2015
    Rite Aid Introduces Receutics Active Skin Repair Line Feb 16 2015
    RITE AID CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Feb 13 2015
    With purchase of EnvisionRx, Rite Aid gets in on the drug intermediary racket Feb 12 2015
    How CVS turned its cigarette ban into a strategic weapon Feb 12 2015
    Rite Aid (RAD) Jumps 6.6% on TPG's EnvisionRx Buyout - Analyst Blog Feb 12 2015
    Rite Aid (RAD) Worth Watching: Stock Moves 6.6% Higher - Tale of the Tape Feb 12 2015
    Cramer: Thanks Europe-good news for your portfolio Feb 11 2015
    Rite Aid Stock Soars, Steps Up Competition With CVS Feb 11 2015
    Envision Pharmaceutical Holdings, Inc. -- Moody's: Envision Pharmaceutical's ratings are unchanged... Feb 11 2015
    Rite Aid buys pharmacy benefit manager EnvisionRx for $2 billion Feb 11 2015
    Stocks End Mixed: Molina Healthcare Rises Again Feb 11 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK